{
  "parties": [
    "iBio Inc., a Public corporation, with a location at iBio Inc., 600 Madison Ave,Suite 01601 NY, NY 10022-1735",
    "Beijing CC-Pharming Ltd"
  ],
  "effective_date": null,
  "governing_law": "the State of Texas",
  "payment_terms": null,
  "termination_clause": {
    "text": "termination of this Agreement but whose period of performance extends beyond the expiration or termination ofthis Agreement.6.2The term of any SOW will be as provided in the Statement of Work.6.3If either Party to this Agreement fails to perform or violates any material obligation of this Agreement, then, upon thirty (30) days writtennotice to the breaching Party specifying such failure or violation, the non-breaching Party may terminate this Agreement without liability,unless: (a) the failure or violation specified in the default notice has been cured within the thirty (30) day notice periodÍ¾ or (b) the failure orviolation reasonably requires more than thirty (30) days to correct, and the breaching Party has begun substantial corrective action toremedy the failure or violation within the thirty (30)",
    "start": 15112,
    "end": 15923,
    "confidence": 0.72,
    "source": "regex"
  },
  "_doc_id": "Development__IbioInc_20200313_8-K_EX-10.1_12052678_EX-10.1_Development Agreement.txt",
  "_char_count": 30056,
  "_provenance": {}
}